Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium ...

Hospira announced a voluntary recall of one lot of Sodium Bicarbonate Injection 8.4%, USP, due to particulate presence within a single-dose glass fliptop vial from a confirmed complaint.

Adverse events related to use of sodium bicarbonate injection should be reported to the company via email at [email protected], by fax to 610-650-7781 or 610-650-0170, or by phone at 1-800-734-9236.

Sodium Bicarbonate Injection is indicated for the treatment of metabolic acidosis. To date, the Company has received 5 reports of flying glass leading to injured skin, eye, and/or other parts.

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC ...

Sodium Bicarbonate Injection supply is historically unstable, creating a challenging environment for hospitals and the patients they serve," said Peter Karas, ...

Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making ...

The three drugs are 8.4% sodium bicarbonate injection, 50 milliequivalent/50 milliliter vials, which treat metabolic acidosis; midazolam in 0.8% sodium chloride injection, 100 milligram/100 ...

Gino Agnelly, the head pharmacist at Providence Hospital in Mobile, Ala., has had to be careful with his supply of sodium bicarbonate injections. MEGGAN HALLER The New York Times Hospitals around ...

Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP, 50 mg/5mL ...